People living with HIV respond well to COVID-19 infection and vaccination

Researchers examine the antibody response to natural infection or COVID-19 vaccination in individuals living with HIV infection.

Glaukos eyes FDA approval for ocular therapy after Phase III win

Epioxa was developed to be used during the corneal cross-linking procedure to treat keratoconus. Credit: MacroEcon/Shutterstock. Glaukos plans to file for US approval of its

October 17, 2024

Kristen Hege reaches the end of one trail, and the beginning of the next

Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you

February 28, 2024

Living digital camera: scientists capture light patterns in DNA for image storage

Researchers described a technique of capturing two-dimensional (2D) light patterns into DNA.

July 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.